Advances in cancer prevention and treatment reported at this week´s premier European congress for specialists in gynaecological cancers show that care is being more effectively tailored to the needs of individual women, so that survival can be improved without the cost of added complications and reduced quality of life.
In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.
The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only congress in Europe that covers the entire spectrum of cancer from basic science and translational research, to prevention, treatment, nursing and supportive care for all types of tumours.
A new initiative designed to inform and educate policymakers at national, European, and global level about the needs of the oncology community was launched at Europe's largest cancer congress, ECCO 15 — ESMO 34, in Berlin. The European Academy of Cancer Sciences will help to keep the interests of cancer patients at the forefront of the policy agenda, and avoid policy decisions that had a…
Removal of the primary breast tumour in women whose cancer has already spread to other parts of the body can have a significant effect on their survival, Dutch researchers have found. Their research meant that women who were diagnosed at a late stage of the disease could expect to survive longer. They discovered that those patients who had received surgery survived for considerably longer than…
Completion of a Phase I clinical trial has demonstrated the great promise of a completely new type of cancer treatment, according to results announced this June in The New England Journal of Medicine by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital in the United Kingdom, working with pharma firm AstraZeneca.
Researchers around the globe are studying whether a genomic test, developed with micro-array technology, is superior to traditional methods in assessing aggressive breast cancer, and therefore could spare a considerable percentage of women from the onslaught of chemotherapy The Breast International Group (BIG) in Brussels, Belgium, manages TRANSBIG, an international network created to avoid…
3D Net Perfusion, new software developed by The Institute of Cancer Research (ICR) working with Biotronics3D, aims to improve the accuracy of MRI scan analysis and treatment efficacy by extracting data from tumour images and transforming it into usable information. In addition, the analytical tool provides a method to visualise and measure blood supply to cancers - a crucial factor in tumour…
During a gathering of clinicians, scientists and economists at this year's Medical Technology Congress (Treffpunkt für Medizintechnik) held in Berlin's Charité Hospital, all 17 lectures focused on cancer treatments. Bettina Döbereiner reports
A paper of Professor Christiane K Kuhl and her colleagues had discovered that, to detect pre-invasive breast cancer (DCIS), the addition of high-resolution MRI and state-of-the-art mammography offered a significantly higher sensitivity compared with state-of-the-art mammography.
"In-vitro veritas", the slogan of the 18th European Congress of Clinical Chemistry and Laboratory Medicine, which took place in June, underlined the significance of in vitro diagnostics for healthcare, and the presentations by 90 speakers, in 32 scientific sessions and 29 industry sponsored workshops, demonstrated the rich variety of developments.
Intra-operative radiotherapy (IORT) using the Intrabeam system from Carl Zeiss has been confirmed as a new alternative to the current approach to radiotherapy for breast cancer, by scientists and physicians at a symposium on IORT technological developments held in Germany.
Breast-specific gamma imaging (BSGI) is a promising new technology designed to supplement mammography and breast ultrasound examinations when these show suspicious findings. By helping to detect early stage breast cancer it may reduce significantly the number of negative biopsies performed. Dilon Technologies (Newport News, Virginia), pioneer of this technology, received the CE Mark to sell its…
Studies show promise for fast, 5-day therapy for early-stage breast cancer patients
Not so long ago this country, of considerable linguistic division, was a split into three regions, referred to as Flemish (with five provinces), Walloon (with five provinces) and the Brussels Capital. Each has its own parliament, with governments responsible for their individual region's affairs; these include health. Dr Catherine Breucq, head of the Breast Imaging Department at Brussels…
Every year the German Society for Senology congress facilitates interdisciplinary breast cancer discussion between gynaecologists, radiologists, surgeons, pathologists, internists, radio-oncologists and plastic surgeons. In an interview with Karoline Laarmann, of European Hospital, radiologist Professor Ingrid Schreer (right), head of the Breast Centre at the University Women's Hospital in Kiel,…
Women in families with a history of breast cancer have a significantly higher risk of developing the disease.
Analogue screening systems are gradually being replaced by digital mammography systems, and breast cancer screening programmes are increasing sales. The majority of European countries have implemented in European countries, but in some others their introduction is slow, but steady. Additionally, Europe has significant geographic diversity, and remote places served by mobile screening units…
Although the majority of the 18,000 participants at ECR 2009 were radiologists, medical writer Rob Skelding reports that a specific session for radiographers was well attended. The event also underlined the value of their interpretive skills
A new partnership between BreastHealth UK (BHUK) and Lab21 Ltd aims to offer women predictive genetic testing for breast cancer risk. BHUK, which offers personalised, private breast screening services, has launched a Breast Health Risk Assessment Service.
The figures prove that even in the face of current economic difficulties, first-class quality still ensures success. 274 scientific presentations and 25 industry-supported Satellite Symposia and Hands-on Workshops bore witness to the most recent developments in science and research.
It is not only the examination itself that makes mammography screening programmes successful, an intelligent integration of the data into the hospital´s RIS is another integral part of it. Since last year, a new mammography module for the Carestream RIS, is improving mammography screening administration in three of Denmark's five regions. Development work on the innovative module was initiated…
New possibilities in breast ultrasound comprise techniques for optimizing image quality such as tissue harmonic imaging (THI) and frequency compounding (FC), tools for post-processing US raw data such as strain imaging (elastography), and the use of Realtime-Sonoelastography, PD Dr. Anke Thomas from the Charité in Berlin, Germany, introduced her speech at the Hitachi Symposium Realtime Tissue…
Arriving at the Austrian Congress Center in Vienna, a pink truck is striking the eyes of the visitors of ECR. The truck took the long way from Belgium to Austria to demonstrate a pretty successful project of the University Hospital Brussels: A mobile mammography unit that examines women living in rural areas and who otherwise would probably not join the screening programm. The trailer was…
Within the last three decades, contrast-enhanced magnetic resonance breast imaging has gone through substantial developments, evolving to become the imaging modality with the highest sensitivity for breast cancer detection. The indication to perform breast MRI ranges widely, including high-risk patients, dense breast tissue and therapy monitoring under primary systemic therapy.